Clinical Trial Update: Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating neoadjuvant endocrine therapy for ER-positive, HER2-negative early-stage breast cancer; the study is currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Node-negative Breast Cancer

Snippet

Sponsor: Irada Ibrahim-zada | Conditions: Breast Cancer, HER2-negative Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING